1. Home
  2. SBFM vs TWAV Comparison

SBFM vs TWAV Comparison

Compare SBFM & TWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunshine Biopharma Inc.

SBFM

Sunshine Biopharma Inc.

N/A

Current Price

$1.15

Market Cap

4.3M

Sector

Health Care

ML Signal

N/A

Logo TaoWeave Inc. Common Stock

TWAV

TaoWeave Inc. Common Stock

N/A

Current Price

$1.29

Market Cap

4.9M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
SBFM
TWAV
Founded
2006
N/A
Country
United States
United States
Employees
N/A
130
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
4.9M
IPO Year
2008
2000

Fundamental Metrics

Financial Performance
Metric
SBFM
TWAV
Price
$1.15
$1.29
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
393.8K
25.0K
Earning Date
04-03-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
90.77
EPS
N/A
0.43
Revenue
$36,305,891.00
$2,437,000.00
Revenue This Year
$40.47
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.13
Revenue Growth
4.11
2.48
52 Week Low
$0.25
$0.58
52 Week High
$3.05
$2.58

Technical Indicators

Market Signals
Indicator
SBFM
TWAV
Relative Strength Index (RSI) 40.08 43.47
Support Level $1.09 $1.26
Resistance Level $1.29 $1.49
Average True Range (ATR) 0.09 0.09
MACD 0.02 -0.01
Stochastic Oscillator 40.07 13.04

Price Performance

Historical Comparison
SBFM
TWAV

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About TWAV TaoWeave Inc. Common Stock

TaoWeave Inc is a digital asset company. The company offers investors a regulated, publicly traded vehicle to gain exposure to the decentralized AI economy. The company aims to invest in the Bittensor ecosystem through partnerships with subnets, miners, and validators, and operates with zero debt by maintain appropriate cash reserves. The Company currently operates in three segments: (1) "Digital Assets", which represents the business surrounding treasury activity with Bittensor, (2) Collaboration Products which represents the business surrounding Mezzanine product offerings, and (3) Managed Services, which represents the business surrounding managed services for video collaboration and network solutions.

Share on Social Networks: